MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS266 Study Title Droplet microfluidics-based iX-seq uncovers cross-feeding interactions between Phascolarctobacterium faecium and Eubacterium limosum in the gut microbiota Study Description Droplet microfluidics is an innovative technology with notable potential for high-throughput separation and cultivation of bacterial isolates from complex microbial communities such as the gut microbiota. In this study, we utilized droplet microfluidics in tandem with 16S rRNA amplicon sequencing to screen for cross-feeding bacteria, hereafter referred to as iX-seq, in a human fecal sample. We identified Phascolarctobacterium faecium and Eubacterium limosum as unidirectional cross-feeders, wherein P. faecium growth appeared to be dependent on E. limosum-derived 2-oxoglutarate for survival when co-cultured in modified YCFA medium. As a key intermediate in the succinate metabolic pathway, 2-oxoglutarate was likely utilized as a nutrient source by the succinate-metabolizing P. faecium. Furthermore, P. faecium failed to colonize the intestines of germ-free mice without co-inoculation with E. limosum, further evidencing their cross-feeding relationship. These findings demonstrate the utility of droplet microfluidics for uncovering the mechanisms of microbial interactions within the complex gut environment. Experimental Design stimulus or stress design Experimental Factor Name treatment Experimental Factor Type treatment Person Last Name Fukuda Komatsu Person First Name Shinji Mitsuko Person Mid Initials Person Affiliation Institute for Advanced Biosciences, Keio University Institute for Advanced Biosciences, Keio University Person Roles submitter submitter PubMed ID Publication DOI Protocol Name Sample collection Extraction Capillary Electrophoresis 1 Capillary Electrophoresis 2 Mass spectrometry 1 Mass spectrometry 2 Data processing Metabolite identification Protocol Type Sample collection Extraction Capillary Electrophoresis Capillary Electrophoresis Mass spectrometry Mass spectrometry Data processing Metabolite identification Protocol Description Germ-free (GF) BALB/c mice (female, 6-20 weeks of age) were housed in gnotobiotic isolators and fed an autoclaved, standard rodent chow diet (CMF, Oriental Yeast Co., Ltd., Tokyo, Japan). Phascolarctobacterium faecium was cultured in GAM medium supplemented with 1% (w/v) succinate for 48 hours. After cultivation, the cultures were centrifuged at 10,000 × g for 5 minutes at room temperature, and the supernatant was discarded. The resulting cell pellets were resuspended in freshly prepared GAM medium. Eubacterium limosum was cultured in GAM medium for 24 hours and was processed in the same manner as P. faecium. The mice were inoculated with P. faecium or E. limosum cells by oral gavage of 200 µL of ten to the eighth power colony-forming units. During the 4-week experiment, feces were collected at weekly intervals for additional testing. "10 mg of freeze-dried fecal samples were mixed with 500 μL of methanol. Samples were homogenized using a Shake Master NEO (Bio Medical Science Inc.) with 100 mg of 0.1 mm zirconia/silica beads and four 3 mm zirconia beads (Tomy Seiko Co., Ltd.). Subsequently, 200 μL of Milli-Q water containing 200 μM methionine sulfone and 200 μM D-camphor-10-sulfonic acid, along with 500 μL of chloroform, were added to the mixture, followed by a second round of shaking. The samples were then centrifuged at 20,000 × g for 10 minutes at 4 °C. The resulting supernatant was transferred to a filter column with a 5 kDa molecular weight cut-off (Ultrafree MC-PLHCC, 250/pk, Human Metabolome Technologies) for metabolite extraction. The flow-through was dried using a centrifugal concentrator (Labconco Corp.) at 40 °C for 3 hours. Finally, the dried residue was reconstituted in 50 μL of Milli-Q water containing internal standards (200 μM 3-aminopyrrolidine and 200 μM trimesic acid). For capillary electrophoresis, the reconstituted solution was further diluted with Milli-Q water: a 5-fold dilution was performed for anion mode, and a 2-fold dilution was used for cation mode." "Extracted metabolites were separated using an Agilent 7100 capillary electrophoresis system (Agilent Technologies, Inc.) operated in negative mode. A COSMO(+)-type capillary (Nacalai Tesque, Inc.) was employed for separation. A 50 mM ammonium acetate solution (pH 8.5) served as the electrolyte for CE separation. Approximately 30 nL of sample solution was injected at 50 mbar for 30 seconds, and a voltage of -30 kV was applied. The capillary temperature was maintained at 20 °C, and the sample tray was cooled to below 5 °C." "Extracted metabolites were separated using an Agilent 7100 capillary electrophoresis system (Agilent Technologies, Inc.) operated in positive mode. A fused silica capillary (Molex Inc.) was employed for separation. A 1 M formic acid solution served as the electrolyte for CE separation. Approximately 5 nL of sample solution was injected at 50 mbar for 5 seconds, and a voltage of 30 kV was applied. The capillary temperature was maintained at 20 °C, and the sample tray was cooled to below 5 °C." "The levels of extracted metabolites were measured using an Agilent 6210 time-of-flight mass spectrometer (Agilent Technologies, Inc.) operated in negative ion mode. A sheath liquid consisting of 5 mM ammonium acetate in 50% methanol-water (v/v), containing 0.1 μM Hexakis(2,2-difluoroethoxy)phosphazene, was delivered at a flow rate of 10 μL/min. ESI-TOFMS analysis was performed in negative ion mode with a capillary voltage of 3,500 V. Heated dry nitrogen gas was supplied at a flow pressure of 7 psig, with the heater temperature maintained at 300 °C. For TOFMS, the fragmentor, skimmer, and Oct RFV voltages were set to 100 V, 50 V, and 200 V, respectively. Automatic recalibration of each acquired spectrum was conducted using reference masses of internal standards. The ^13C-labeled acetic acid (m/z 120.038339) and Hexakis(2,2-difluoroethoxy)phosphazene + CH3COOH (m/z 680.035541) were used as lock masses for exact mass measurements. Exact mass data were acquired at a rate of 10 spectra per second over an m/z range of 50 to 1,000." "The levels of extracted metabolites were measured using an Agilent 1969 time-of-flight mass spectrometer (Agilent Technologies, Inc.) operated in positive ion mode. A sheath liquid consisting of 50% methanol-water (v/v) containing 0.1 μM Hexakis(2,2-difluoroethoxy)phosphazene was delivered at a flow rate of 10 μL/min. ESI-TOFMS was operated in positive ion mode with a capillary voltage of 4,000 V. Heated dry nitrogen gas was supplied at a flow pressure of 7 psig, with the heater temperature maintained at 300 °C. In TOFMS, the fragmentor, skimmer, and Oct RFV voltages were set to 75 V, 50 V, and 125 V, respectively. Automatic recalibration of each acquired spectrum was performed using reference masses of internal standards. The methanol adduct ion (m/z 66.063061) and Hexakis(2,2-difluoroethoxy)phosphazene (m/z 622.028963) were used as lock masses for exact mass measurements. Exact mass data were acquired at a rate of 10 spectra per second over an m/z range of 50 to 1,000." The raw data were processed using MasterHands (ver. 2.19.0.1), an in-house software developed for metabolomic analysis. "The peaks were identified using the in-house software MasterHands, based on matched m/z values and normalized migration times of corresponding standard compounds, when available. For peaks that did not match any standard compounds, concomitant signals - such as isotopic and fragment peaks - were excluded by comparing the m/z values and normalized migration times of paired peaks, applying an error tolerance of 20 ppm and 0.01 min. This filtering step yielded a set of peaks, hereafter referred to as components, that were presumed to originate from metabolites. Candidate compounds were selected from the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Human Metabolome Database (HMDB). The composition formulae of these candidates were validated by comparing their theoretical isotope distribution patterns with those obtained from the measured mass spectrometry data." Protocol Parameters Post extraction;Derivatization CE instrument;Autosampler model;Column model;Column type CE instrument;Autosampler model;Column model;Column type Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Scan polarity;Scan m/z range;Instrument;Ion source;Mass analyzer Protocol Hardware Protocol Software Public Release Date 2025-11-27 Term Source Name Term Source File Term Source Version SDRF File MTBKS266.sdrf.txt Comment[Study type] metabolite profiling Comment[Experiment type] capillary electrophoresis-mass spectrometry Comment[Submission type] CE-MS Comment[BioProject] PRJDB37686 Comment[Related study] Comment[Contributor] Comment[Submission Date] 2025-10-30 Comment[Last Update Date] 2025-11-27